Belgium· BE-AMP-SAM379251-00
Brevibloc 10 mg/ml
A esmolol product containing esmolol hydrochloride, registered in Belgium by Baxter. The same ATC class is registered in 16 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Esmolol is registered in 16 of 19 countries.
Countries holding a registration under ATC C07AB09 (esmolol), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 9 of them publish a price we can compare per daily dose
Esmolol · ATC C07AB09
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Esmolol Hydrochloride
- Manufacturer
- Baxter
- Country
- Belgium (BE)
- ATC code
- C07AB09
- ATC class
- Esmolol
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb1184449
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
196 interactions on record for esmolol.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Esmolol · interactions on record
196 records
- 11 severe
- 139 moderate
- 8 minor
Most severe, free to view
- DolasetronA04AA04severe
- TheophyllinC01EB28severe
- CeritinibL01ED02severe
- CeritinibL01XE28severe
38 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Esmolol in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandEsmolol OrPha 100 mg/10 ml, InjektionslösungOrPha Swiss GmbH
- CzechiaESMOCARDOrpha-Devel Handels und Vertriebs GmbH, Purkersdorf
- SpainBREVIBLOC 10 mg/ml SOLUCION INYECTABLEBaxter S.L.
- FinlandBreviblocBaxter Oy
- NorwayBreviblocBaxter Medical AB
- SwedenBrevibloc 10 mg/ml Injektionsvätska, lösningBaxter Medical AB
- United StatesBreviblocBaxter Healthcare Company
- United KingdomBrevibloc Concentrate 2.5g/10ml solution for infusion ampoulesBaxter Healthcare Ltd
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Brevibloc, Esmolol Amomed
- Cyprus · Brevibloc, Esmobeta
- Czechia · Esmocard, Esmocard Lyo
- Germany · Brevibloc, Esmocard
- Denmark · Brevibloc
- Spain · Brevibloc, Esmolol Aurovitas
- Finland · Brevibloc
- France · Brevibloc, Esmocard
- United Kingdom (Northern Ireland) · Brevibloc Premixed, Esmolol Hikma Farmacêutica (Portugal)
- Greece · Brevibloc, Esmobeta
- Croatia · Esmocard
- Ireland · Brevibloc Premixed
- Italy · Brevibloc, Esmocard
- Luxembourg · Brevibloc
- Malta · Brevibloc Premixed
- Netherlands · Brevibloc, Esmolol Hcl Hikma
- Norway · Brevibloc
- Portugal · Brevibloc, Esmolol Eugia
- Sweden · Brevibloc
- Slovenia · Esmocard, Esmocard Lyo
- Slovakia · Esmocard, Esmocard Lyo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/455aea56-f7b8-44fb-8451-3b3d41805cfa GET /v1/drugs/455aea56-f7b8-44fb-8451-3b3d41805cfa?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Brevibloc 10 mg/ml",
"name_fr": "Brevibloc 10 mg/ml",
"name_nl": "Brevibloc 10 mg/ml",
"amp_code": "SAM379251-00",
"strengths": [
"10.0000",
"2.8000",
"5.9000"
],
"pack_count": 4,
"substances": [
"Esmolol Hydrochloride",
"Sodium Acetate",
"Sodium Chloride",
"Sodium Hydroxide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Esmolol",
"authorisation_numbers": [
"BE379251"
]
}See everything about esmolol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.